Bacterial bile acid modification and potential pharmaceutical applications

Research output: Contribution to journalReview article

Abstract

Modification of bile acids by gut bacteria has the potential to influence host physiology and risk of metabolic disease through effects on bile acid signalling, and may be involved in the pathogenesis of colorectal cancer via a range of mechanisms. We have previously examined the distribution, abundance, and function of bile salt hydrolase activity (a key microbial enzyme involved in bacterial bile acid modification) in the human gut microbiome, and found this to be a conserved function of the gut microbiota, which may be of pharmaceutical interest. This article summarises current knowledge regarding the potential for microbial bile acid metabolism to influence human health and highlights possibilities for pharmaceutical intervention. Where possible the reader is referred to recent comprehensive reviews of these subjects, through which the wider literature may be accessed.

Original languageEnglish
Pages (from-to)94-100
Number of pages7
JournalJournal of Applied Therapeutic Research
Volume8
Issue number3
Publication statusPublished - 20 Oct 2011

Fingerprint

Bile Acids and Salts
choloylglycine hydrolase
Pharmaceutical Preparations
Microbiota
Metabolic Diseases
Colorectal Neoplasms
Bacteria
Health
Enzymes
Gastrointestinal Microbiome

Keywords

  • Bile acids
  • Bile salt hydrolase
  • Colorectal cancer
  • Gut microbiota
  • Metagenomics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Bacterial bile acid modification and potential pharmaceutical applications. / Jones, B. V.

In: Journal of Applied Therapeutic Research, Vol. 8, No. 3, 20.10.2011, p. 94-100.

Research output: Contribution to journalReview article

@article{7347bd7c135b4466913963d1fcfbf3c5,
title = "Bacterial bile acid modification and potential pharmaceutical applications",
abstract = "Modification of bile acids by gut bacteria has the potential to influence host physiology and risk of metabolic disease through effects on bile acid signalling, and may be involved in the pathogenesis of colorectal cancer via a range of mechanisms. We have previously examined the distribution, abundance, and function of bile salt hydrolase activity (a key microbial enzyme involved in bacterial bile acid modification) in the human gut microbiome, and found this to be a conserved function of the gut microbiota, which may be of pharmaceutical interest. This article summarises current knowledge regarding the potential for microbial bile acid metabolism to influence human health and highlights possibilities for pharmaceutical intervention. Where possible the reader is referred to recent comprehensive reviews of these subjects, through which the wider literature may be accessed.",
keywords = "Bile acids, Bile salt hydrolase, Colorectal cancer, Gut microbiota, Metagenomics",
author = "Jones, {B. V.}",
year = "2011",
month = "10",
day = "20",
language = "English",
volume = "8",
pages = "94--100",
journal = "Journal of Applied Therapeutic Research",
issn = "1029-2659",
publisher = "Euromed Communications",
number = "3",

}

TY - JOUR

T1 - Bacterial bile acid modification and potential pharmaceutical applications

AU - Jones, B. V.

PY - 2011/10/20

Y1 - 2011/10/20

N2 - Modification of bile acids by gut bacteria has the potential to influence host physiology and risk of metabolic disease through effects on bile acid signalling, and may be involved in the pathogenesis of colorectal cancer via a range of mechanisms. We have previously examined the distribution, abundance, and function of bile salt hydrolase activity (a key microbial enzyme involved in bacterial bile acid modification) in the human gut microbiome, and found this to be a conserved function of the gut microbiota, which may be of pharmaceutical interest. This article summarises current knowledge regarding the potential for microbial bile acid metabolism to influence human health and highlights possibilities for pharmaceutical intervention. Where possible the reader is referred to recent comprehensive reviews of these subjects, through which the wider literature may be accessed.

AB - Modification of bile acids by gut bacteria has the potential to influence host physiology and risk of metabolic disease through effects on bile acid signalling, and may be involved in the pathogenesis of colorectal cancer via a range of mechanisms. We have previously examined the distribution, abundance, and function of bile salt hydrolase activity (a key microbial enzyme involved in bacterial bile acid modification) in the human gut microbiome, and found this to be a conserved function of the gut microbiota, which may be of pharmaceutical interest. This article summarises current knowledge regarding the potential for microbial bile acid metabolism to influence human health and highlights possibilities for pharmaceutical intervention. Where possible the reader is referred to recent comprehensive reviews of these subjects, through which the wider literature may be accessed.

KW - Bile acids

KW - Bile salt hydrolase

KW - Colorectal cancer

KW - Gut microbiota

KW - Metagenomics

UR - http://www.scopus.com/inward/record.url?scp=80054114098&partnerID=8YFLogxK

M3 - Review article

VL - 8

SP - 94

EP - 100

JO - Journal of Applied Therapeutic Research

JF - Journal of Applied Therapeutic Research

SN - 1029-2659

IS - 3

ER -